Effects of the HIV-1 Viral Protein TAT on Central Neurotransmission: Role of Group I Metabotropic Glutamate Receptors

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 339-356

  Neri, Elisa ^a   Musante, Veronica ^a   Pittaluga, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; METABOTROPIC RECEPTOR; PRESYNAPTIC RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE PRODUCTS, TAT; HIV-1; HUMANS; NEUROTRANSMITTER AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PRESYNAPTIC; SYNAPTIC TRANSMISSION;

EID: 34547244064     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82018-6     Document Type: Review

References (51)

1. Brake D.A., Debouck C., and Biesecker G. Identification of an Arg-Gly-Asp (RDG) cell adhesion site in human immunodeficiency virus type 1 transactivation protein Tat. J. Cell Biol. 111 (1990) 1275-1281
2. Chandra T., Mier W., Konig H.G., Hirzel K., Kogel D., Schuler T., Chandra A., Demirhan I., and Laube B. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-D-aspartate receptor subunits. Neuroscience 134 (2005) 145-153
3. Cheng J., Nath A., Knudsen B., Hochman S., Geiger J.D., Ma M., and Magnuson D.S.K. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 82 (1998) 97-106
4. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
5. Diesing T.S., Swindells S., Gelbard H., and Gendelman H.E. HIV-1-associated dementia: A basic science and clinical perspective. AIDS Read. 12 (2002) 358-368
6. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
7. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., and Gallo C. Release, uptake and effects of extracellular HIV-1 tat protein on cell growth in viral transactivation. J. Virol. 67 (1993) 277-287
8. Everall I.P., Heaton R.K., Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M., and Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol. 9 (1999) 209-217
9. Feligioni M., Raiteri L., Pattarini R., Grilli M., Bruzzone S., Cavazzani P., Raiteri M., and Pittaluga A. The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms. J. Neurosci. 23 (2003) 6810-6818
10. Ghersi C., Bonfanti A., Manzari B., Feligioni M., Raiteri M., and Pittaluga A. Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: Study with receptor antagonists. Neurochem. Int. 42 (2003) 283-292
11. Green J.D., and Lowenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 (1988) 1179-1188
12. Haughey N.J., Holden C.P., Nath A., and Geiger J.D. Involvement of inositol 1,4,5-trisphospahte-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat. J. Neurochem. 73 (1999) 1363-1374
13. Haughey N.J., Nath A., Mattson M.P., Slevin J.T., and Geiger J.D. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 78 (2001) 457-467
14. Jones S.L. Integrins: Possible functions in the adult CNS. Trends Neurosci. 19 (1996) 68-72
15. Kelly G.D., Ensoli B., Gunthel C.J., and Offermann M.K. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells. AIDS 12 (1998) 1753-1761
16. Kolson D.L., Buchhalter J.U., Collman R., Hellmig B., Farell C.F., Debourek C., and Gonzales-Scarano F. HIV-1 Tat alters normal organization of neurones and astrocytes in primary rodent brain cell cultures: RDG sequence dependence. AIDS Res. Hum. Retroviruses 9 (1993) 677-685
17. Kruman I.I., Nath A., and Mattson M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154 (1998) 276-288
18. Lawrence D.M., and Major E.O. HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect. 4 (2002) 301-308
19. Longordo F., Feligioni M., Chiaramonte G., Sbaffi P., Raiteri M., and Pittaluga A. The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons. J. Pharmacol. Exp. Ther. 317 (2006) 1097-1105
20. Magnuson D.S.K., Knudsen B.E., Geiger J.D., Brownstone R.M., and Nath A. Human immunodeficiency virus type 1 Tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37 (1995) 373-380
21. Masliah E., Achim C.L., Ge N., DeTeresa R., Terry R.D., and Wiley C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32 (1992) 321-329
22. Masliah E., Ge N., and Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10 (1996) 57-67
23. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan J.A., Nelson J.A., Atkinson J.H., and Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann. Neurol. 42 (1997) 963-972
24. McArthur J.C. HIV-1 dementia: An evolving disease. J. Neuroimmunol. 157 (2004) 3-10
25. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., Jacobson L.P., Visscher B.R., Concha M., et al. Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43 (1993) 2245-2252
26. McArthur J.C., Brew B.J., and Nath A. Neurological complications of HIV infection. Lancet Neurol. 4 (2005) 543-555
27. 2+ channels and endogenous dopamine. Mol. Cell. Neurosci. 31 (2006) 284-292
28. Minghetti L., Visentin S., Patrizio M., Franchini L., Ajmone-Cat M.A., and Levi G. Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem. Res. 29 (2004) 965-978
29. Mothet J.P., Fossier P., Meunier F.M., Stinnakre J., Tauc L., and Baux G. Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia. J. Physiol. 507 (1998) 405-414
30. Nath A., and Geiger J.D. Neurobiological aspects of HIV infections: Neurotoxic mechanisms. Prog. Neurobiol. 54 (1998) 19-33
31. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D.S.K., Haughey N., and Geiger J.D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70 (1996) 1475-1480
32. Navia B.A., Jordan B.D., and Price R.W. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19 (1986) 517-524
33. Peruzzi F., Bergonzini V., Aprea S., Reiss C., Sawaya B.E., Rappaport J., Amini S., and Khalili K. Cross talk between growth factors and viral and cellular factors alters neuronal signalling pathways: Implication for HIV-associated dementia. Brain Res. Brain Res. Rev. 50 (2005) 114-125
34. Pittaluga A., and Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmacol. 191 (1990) 231-234
35. Pittaluga A., and Raiteri M. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur. J. Neurosci. 6 (1994) 1743-1749
36. Pittaluga A., Bonfanti A., and Raiteri M. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedeberg's Arch. Pharmacol. 356 (1997) 29-38
37. Pittaluga A., Pattarini R., Feligioni M., and Raiteri M. N-methyl-d-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. J. Neurochem. 76 (2001) 139-148
38. Pittaluga A., Segantini D., Feligioni M., and Raiteri M. Extracellular protons differentially potentiate the responses of native AMPA receptors subtypes regulating neurotransmitter release. Br. J. Pharmacol. 144 (2005) 293-299
39. Prendergast M.A., Trent Rogers D., Mulholland P.J., Littleton J.M., Wilkins Jr. L.H., Self R.L., and Nath A. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor. Brain Res. 954 (2002) 300-307
40. Raiteri M., Angelini F., and Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25 (1974) 411-414
41. Raiteri M., Garrone B., and Pittaluga A. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. J. Pharmacol. Exp. Ther. 260 (1992) 238-242
42. Rosenmund C., Stern-Bach Y., and Stevens C.F. The tetrameric structure of a glutamate receptor channel. Science 280 (1998) 1596-1599
43. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., and Bhraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65 (1991) 961-967
44. Salter M.W., and Kalia L.V. Src kinases: A hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5 (2004) 317-328
45. 2+ that requires function of an N-methyl-d-aspartate receptor polyamine-sensitive site. Brain Res. 995 (2003) 39-45
46. Song L., Nath A., Geiger J.D., Moore A., and Hochman S. Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an allosteric zinc-sensitive site. J. Neurovirol. 9 (2003) 399-403
47. Ungvarski P.J., and Trzcianowska H. Neurocognitive disorders seen in HIV-1 disease. Issues Ment. Health Nurs. 21 (2000) 51-70
48. Wang P., Barks J.D.E., and Silverstein F.S. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience 88 (1999) 585-597
49. Wessenligh S.L., Power C., Glass J.D., Tyor W.R., Mc Arthur J.C., Farber J.M., Griffin J.W., and Griffin D.E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33 (1993) 576-582
50. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., and Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375 (1995) 497-500
51. Wiley C.A., Baldwin M., and Achim C.L. Expression of regulatory and structural mRNA in the central nervous system. AIDS 10 (1996) 943-947